MyVisionTest News Archive

Displaying news items tagged with Lucentis (More tags »)
SELECT PAGE
First <<  1 2 3 4 5 6 7 8 9 10   >> Last

Canadian flag
Mar 30, 2010
The rate of intravitreal injections in Ontario grew 8-fold between 2000 and 2008, according to a new study. Intravitreal injections of VEGF inhibitors surged between 2005 and 2007, with a small number of ophthalmologists performing more than half the injections. Using a population-based retrospective design, we studied monthly fee claims for...

Full Article


Lacquer cracks in pathologic myopia
Mar 30, 2010
Patients with choroidal neovascularization secondary to pathologic myopia appear to do less well after intravitreal Lucentis (ranibizumab) treatment if they have previously been treated with photodynamic therapy (PDT), according to a new study. This was a prospective, multicenter, consecutive, nonrandomized, interventional case series. The...

Full Article


Intraocular pressure
Mar 29, 2010
A series of patients that developed sustained elevation of intraocular pressure (IOP) after intravitreal anti-VEGF injection for the treatment of neovascular age-related macular degeneration (AMD) is presented. Elevation of intraocular pressure (IOP) is a risk factor for glaucoma. If the IOP is elevated, but glaucoma is not present, the patient...

Full Article


Lucentis
Mar 28, 2010
Good results are reported using a variable dosing Lucentis treatment regimen for patients with neovascular AMD. The concept of an variable dosage regimen for the treatment of neovascular AMD with Lucentis was initially initially arose from subgroup analysis of the PIER study results. It appears that some patients can maintain initial...

Full Article


Laser eye surgery
Mar 28, 2010
The combination of reduced-fluence verteporfin photodynamic therapy (PDT) and variable dosing Lucentis (ranibizumab) is safe and effective for patients with neovascular age-related macular degeneration (AMD) over a 24-month period, according to a new study. Photodynamic therapy is performed by intravenous administration of a drug know as...

Full Article


Age-related macular degeneration
Feb 24, 2010
There is no difference in the visual acuity (VA) outcomes after Avastin (bevacizumab) or Lucentis (ranibizumab) treatment for AMD, according to a new study. In 2006, the United States Food and Drug Administration approved the use of Lucentis (ranibizumab) for the treatment of exudative AMD. Before its approval, many ophthalmologists already...

Full Article


Myopic macular degeneration
Feb 23, 2010
There is no significant difference the short-term efficacy and safety of intravitreal Lucentis (ranibizumab) versus Avastin (bevacizumab) in treating myopic choroidal neovascularization (CNV), according to a new study. Choroidal neovascularization (CNV) secondary to pathologic myopia causes severe visual loss in young and middle-aged patients....

Full Article


Laboratory glassware
Feb 20, 2010
Avastin impairs phagocytic activity of retinal pigment epithelial (RPE) cells cultured in a laboratory, according to a new study. The retinal pigment epithelium (RPE) is a layer of "nurse cells" located immediately adjacent to the photoreceptors that provide the photoreceptors with nourishment and removes their waste products. The...

Full Article


Japan
Feb 17, 2010
Lucentis (ranibizumab) is safe and effective for subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) in Japanese patients, according to the EXTEND-I clinical trial. Lucentis was approved for the treatment of wet AMD in Japan in January 2009. The application for approval in Japan was supported by the...

Full Article


CATT trial logo
Jan 26, 2010
The first major clinical trial to compare bevacizumab and ranibizumab in a head-to-head fashion has completed enrollment, and the first data analysis is expected in about 1 year. Although the head-to-head comparison of Avastin (bevacizumab, Genentech) and Lucentis (ranibizumab, Genentech) in CATT (Comparisons of age-related macular degeneration...

Full Article


SELECT PAGE
First <<  1 2 3 4 5 6 7 8 9 10   >> Last
Most Popular
Less - past - More